Featured Posts

To top
Title Image

Delay Tag

19 Oct

European Commission Could Delay Revisions to REACH – WWD

PARIS — The European Commission has just presented its Work Program 2024, and in it there was notably no mention of the Registration, Evaluation, Authorization and Restriction of Chemicals, or REACH, a governing regulation that may impact the wonder industry. During his closing statements of the European Parliament’s plenary session on Tuesday, Maroš Šefčovič, vp of the European Commission, addressed questions, including about REACH, which got here into effect in 2007 within the European Union. Its stated goal is to guard human health and the environment against harmful effects of chemical substances. Šefčovič clarified that if a proposal was already announced in a previous Commission’s work program, it is just not reannounced in the present one. “It’s there, it’s planned, and we're working...
Continue reading
16 Jun

This Drug Could Slow Down Ovary Aging and Delay

Rapamycin, a drug currently undergoing clinical studies at Columbia University, could delay ovary aging and, in turn, delay menopause, while also reducing future symptom severity.  The Columbia clinical study marks the primary time the drug has been tested on humans, because it has previously been tested on animals at several clinics, which showed that it could extend lifespan and slow aging. The trial, led by Dr. Zev Williams, chief of the division of reproductive endocrinology and infertility at Columbia University Fertility Center, and Dr. Yousin Suh, director of the reproductive aging program at Columbia, is a randomized, double-blind, placebo-controlled study taking a look at the consequences of weekly low dose rapamycin on women ages 35 to 42 over the course of three...
Continue reading